Acadia Healthcare (ACHC) Stock Price, News & Analysis

Company Overview

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

Key Stats

• Today's Range: $42.19 to $45.19
• 50-Day Range: $37.50 to $45.41
• 52-Week Range: $36.50 to $87.77
• Volume: 1.95 million shs
• Average Volume: 1.59 million shs
• Market Capitalization: $3.97 billion
• P/E Ratio: 14.01
• Dividend Yield: N/A
• Price Target: $70.22
• Consensus Rating: Moderate Buy

Acadia Healthcare Stock Analysis - MarketRank™

Acadia Healthcare scored higher than 97% of companies evaluated by MarketBeat, and ranked 41st out of 955 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Acadia Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on 7 buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Acadia Healthcare has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 2.65%

Earnings Growth

Earnings for Acadia Healthcare are expected to grow by 2.65% in the coming year, from $3.39 to $3.48 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Acadia Healthcare is 14.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.34.

Price to Earnings Ratio vs. Sector

The P/E ratio of Acadia Healthcare is 14.01, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 89.37.

Price to Earnings Growth Ratio

Acadia Healthcare has a PEG Ratio of 1.84. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Acadia Healthcare has a P/B Ratio of 1.42. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

6.37% of the outstanding shares of Acadia Healthcare have been sold short.

Short Interest Ratio / Days to Cover

Acadia Healthcare has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Acadia Healthcare has recently decreased by 11.24%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Acadia Healthcare does not currently pay a dividend.

Dividend Growth

Acadia Healthcare does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 5.0 / 5
• Environmental Score: -0.69

Percentage of Shares Shorted

6.37% of the outstanding shares of Acadia Healthcare have been sold short.

Short Interest Ratio / Days to Cover

Acadia Healthcare has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Acadia Healthcare has recently decreased by 11.24%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: -0.04

News Sentiment

Acadia Healthcare has a news sentiment score of -0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.48 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Acadia Healthcare this week, compared to 14 articles on an average week.

Search Interest

4 people have searched for ACHC on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

MarketBeat Follows

8 people have added Acadia Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Acadia Healthcare insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 2.00% of the stock of Acadia Healthcare is held by insiders.

ACHC Stock Analysis - Frequently Asked Questions

How have ACHC shares performed this year?

Acadia Healthcare's stock was trading at $39.65 at the beginning of 2025. Since then, ACHC shares have increased by 7.7% and is now trading at $42.72.
View the best growth stocks for 2025 here.

How were Acadia Healthcare's earnings last quarter?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) announced its quarterly earnings data on Wednesday, October, 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. The business's revenue for the quarter was up 8.7% on a year-over-year basis.

Does Acadia Healthcare have any subsidiaries?

Acadia Healthcare subsidiaries include these companies: Polaris Hospital Company, Priory Group, MMO Behavioral Health Systems, Quality Addiction Management, CRC Health Group, Partnerships in Care, Amicare Behavioral Centers, and others.

Who are Acadia Healthcare's major shareholders?

Acadia Healthcare's top institutional investors include Stephens Investment Management Group LLC (1.59%), Charles Schwab Investment Management Inc. (1.33%), Bank of New York Mellon Corp (1.19%) and Vaughan Nelson Investment Management L.P. (1.15%). Insiders that own company stock include Debra K Osteen, Christopher L Howard, David M Duckworth, John S Hollinsworth, William Grieco, Wade D Miquelon and William M Petrie.
View institutional ownership trends.

How do I buy shares of Acadia Healthcare?

Shares of ACHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Acadia Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Acadia Healthcare investors own include Waste Connections (WCN), American Water Works (AWK), DiamondRock Hospitality (DRH), The RMR Group (RMR), AUO (AUOTY), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

• Last Earnings: 10/30/2024
• Today: 2/06/2025
• Next Earnings (Estimated): 2/25/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Specialty outpatient clinics, not elsewhere classified
• Sub-Industry: Health Care Facilities
• Current Symbol: NASDAQ:ACHC
• CUSIP: 00404A10
• CIK: 1520697
• Web: www.acadiahealthcare.com
• Phone: (615) 861-6000
• Fax: 615-261-9685
• Employees: 23,500
• Year Founded: 2005

Price Target and Rating

• Average Stock Price Target: $70.22
• High Stock Price Target: $102.00
• Low Stock Price Target: $43.00
• Potential Upside/Downside: +64.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.78
• Research Coverage: 9 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $3.05
• Trailing P/E Ratio: 14.01
• Forward P/E Ratio: 12.60
• P/E Growth: 1.84
• Net Income: $-21,670,000.00
• Net Margins: 8.99%
• Pretax Margin: 12.29%
• Return on Equity: 11.12%
• Return on Assets: 5.77%

Debt

• Debt-to-Equity Ratio: 0.60
• Current Ratio: 1.07
• Quick Ratio: 1.07

Sales & Book Value

• Annual Sales: $3.12 billion
• Price / Sales: 1.27
• Cash Flow: $4.63 per share
• Price / Cash Flow: 9.22
• Book Value: $30.17 per share
• Price / Book: 1.42

Miscellaneous

• Outstanding Shares: 92,885,000
• Free Float: 91,027,000
• Market Cap: $3.97 billion
• Optionable: Optionable
• Beta: 1.30